Patent · US Expired

Monoclonal antibody

US6291239A · kind A · utility

16Cited by

0References

23Claims

0Family size

Inventors

Wolfgang Prodinger · Innsbruck, AT
Michael Schwendinger · Neusiedl am See, AT

Key dates

Filing date	Mar 25, 1999
Grant date	Sep 18, 2001
Priority date	—
Expiry date	Mar 25, 2019

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/34
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A monoclonal antibody (FE8) against human complement receptor type 2 CR2, CD21) which is able to substantially remove C3-derived fragments already attached to CR2, in particular C3dg from CR2 at temperatures of 25.degree. C. and above. Furthermore, the invention covers hybridoma cells and processes to obtain antibodies, as well as therapeutic applications.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.